help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casey, M. L.
Right arrow Articles by MacDonald, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casey, M. L.
Right arrow Articles by MacDonald, P. C.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 4022-4027, Copyright © 1996 by Endocrine Society


ARTICLES

Transforming growth factor-beta inhibits progesterone-induced enkephalinase expression in human endometrial stromal cells

ML Casey and PC MacDonald
Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas 75235, USA. casey@grnctr.swmed.edu

The specific activity of enkephalinase in endometrial tissue of nonpregnant ovulatory women is correlated in a highly significant, positive manner with the plasma level of progesterone. The specific activity and levels of enkephalinase messenger ribonucleic acid and immunoreactive protein also are increased in human endometrial stromal cells in culture by treatment with a synthetic progestin, medroxyprogesterone acetate (MPA), in a time- and dose-dependent manner. From an analysis of the temporal relationship between the specific activity and half-life of enkephalinase in endometrial tissue and the level of progesterone in plasma, it appeared highly likely that some mechanism, in addition to progesterone withdrawal, was operative to reduce enkephalinase activity in endometrium during the late luteal phase of the ovarian cycle before progesterone levels had declined below those known to be effective for progesterone action. In stromal cells previously (and concurrently) treated with MPA (10(-9) mol/L), the addition of transforming growth factor-beta 1 (TGF beta 1) or TGF beta 2 (1 ng/mL) to the medium caused a decrease in enkephalinase specific activity despite the continued presence of MPA. The half-life of enkephalinase (activity) in stromal cells treated with MPA plus TGF beta 1 was 2.8 days, which is similar to the computed half-life for enkephalinase in endometrial tissue during the mid- to late secretory phase of the endometrial cycle (2.5 days). Simultaneous treatment of endometrial stromal cells with MPA (10(-9) mol/L) and TGF beta 1 (1 ng/ mL) prevented the progestin-induced increase in enkephalinase specific activity and immunoreactive enkephalinase protein. Thus, TGF beta acts to oppose the progesterone-induced increase in enkephalinase expression in endometrial stromal cells, even in the continued presence of MPA.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
N. Kane, M. Jones, J. J. Brosens, P. T. K. Saunders, R. W. Kelly, and H. O. D. Critchley
Transforming Growth Factor-{beta}1 Attenuates Expression of Both the Progesterone Receptor and Dickkopf in Differentiated Human Endometrial Stromal Cells
Mol. Endocrinol., March 1, 2008; 22(3): 716 - 728.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M.R. Kim, D.W. Park, J.H. Lee, D.S. Choi, K.J. Hwang, H.S. Ryu, and C.K. Min
Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells
Mol. Hum. Reprod., November 1, 2005; 11(11): 801 - 808.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Ando, T. Nagasaka, M. Nomura, S.-I. Tsukahara, Y. Kotani, S. Toda, Y. Murata, A. Itakura, and S. Mizutani
Premenstrual Disappearance of Aminopeptidase A in Endometrial Stromal Cells around Endometrial Spiral Arteries/Arterioles during the Decidual Change
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2303 - 2309.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. A. Patel and J. R. G. Challis
Cortisol/Progesterone Antagonism in Regulation of 15-Hydroxysteroid Dehydrogenase Activity and mRNA Levels in Human Chorion and Placental Trophoblast Cells at Term
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 700 - 708.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. R.G. Challis, S. G. Matthews, W. Gibb, and S. J. Lye
Endocrine and Paracrine Regulation of Birth at Term and Preterm
Endocr. Rev., October 1, 2000; 21(5): 514 - 550.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
P. Hatthachote and J. I. Gillespie
Complex Interactions Between Sex Steroids and Cytokines in the Human Pregnant Myometrium: Evidence for an Autocrine Signaling System at Term
Endocrinology, June 1, 1999; 140(6): 2533 - 2540.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
T. Morimoto, J. R. Head, P. C. MacDonald, and M. L. Casey
Thrombospondin-1 Expression in Human Myometrium before and during Pregnancy, before and during Labor, and in Human Myometrial Cells in Culture
Biol Reprod, October 1, 1998; 59(4): 862 - 870.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society